Related Experiment Video
Updated: Sep 18, 2025

09:57
Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
2.8K
A CNN-Transformer Fusion Model for Proactive Detection of Schizophrenia Relapse from EEG Signals
Sana Yasin1, Muhammad Adeel1, Umar Draz2
1Department of Computer Science, University of Okara, Okara 56300, Pakistan.
Bioengineering (Basel, Switzerland)
|June 26, 2025
Summary
This study introduces a novel CNN-Transformer fusion model for early schizophrenia relapse detection using electroencephalogram (EEG) data. The advanced framework achieves 97% accuracy, significantly improving early intervention and relapse prevention.
Area of Science:
- Neuroscience and Artificial Intelligence
- Computational Psychiatry
- Biomedical Signal Processing
Background:
- Schizophrenia relapse detection is challenging due to complex neurophysiological dynamics.
- Existing models lack sensitivity, especially in early relapse stages, often using shallow architectures or single data sources.
Purpose of the Study:
- To develop a hybrid CNN-Transformer model for enhanced schizophrenia relapse prediction.
- To integrate electroencephalogram (EEG) signals with clinical and sentiment data for a comprehensive analysis.
Main Methods:
- A CNN-Transformer fusion model was developed for joint spatial-temporal modeling of relapse indicators.
- A multi-resource data fusion pipeline was implemented, integrating EEG, clinical, and sentiment features.
- The model was evaluated against leading baselines using experimental data.
Main Results:
- The proposed model achieved a superior prediction accuracy of 97%.
- Significant improvements in recall and F1-score were observed compared to existing methods.
- The model demonstrated a notable reduction in false negatives, crucial for timely intervention.
Conclusions:
- The CNN-Transformer fusion model offers a robust and interpretable approach to schizophrenia relapse detection.
- This framework advances personalized relapse prevention and continuous mental health monitoring.
- The findings pave the way for scalable, real-world clinical applications.

